Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Cutter

Showing results (181-190 of 333) with videos related to

Pageof 34
Sort By:
Journal of the Neurological Sciences|May 22, 2016
Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trialSamuel F Hunter, Mark Agius, Deborah M Miller, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2025
Extended window of relapse recovery in RRMS: an analysis of the DECIDE datasetJop Mostert, Eva M Strijbis, Miguel D'Haeseleer, et al.
Antimicrobial Resistance and Infection Control|July 14, 2022
Clinical risk factors for admission with Pseudomonas and multidrug-resistant Pseudomonas community-acquired pneumoniaAdeniyi J Idigo, J Michael Wells, Matthew L Brown, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 2, 2013
The Multiple Sclerosis Intimacy and Sexuality Questionnaire -- re-validation and development of a 15-item version with a large US sampleFrederick W Foley, Vance Zemon, Denise Campagnolo, et al.
Statistics in Medicine|May 10, 2024
Novel non-linear models for clinical trial analysis with longitudinal data: A tutorial using SAS for both frequentist and Bayesian methodsGuoqiao Wang, Whedy Wang, Brian Mangal, et al.
Therapeutic Advances in Neurological Disorders|June 18, 2019
Clinical trials in multiple sclerosis: potential future trial designsNavid Manouchehri, Yinan Zhang, Amber Salter, et al.
Multiple Sclerosis and Related Disorders|May 27, 2025
The written symbol digit modalities test in multiple sclerosis is sensitive to cognitive and motor disabilityMatthew A Greenwald, Héctor G Cancel Asencio, Kevin Hu, et al.
Journal of General Internal Medicine|December 22, 2004
A practical randomized trial to improve diabetes careRussell E Glasgow, Paul A Nutting, Diane K King, et al.
Multiple Sclerosis and Related Disorders|April 3, 2026
Comments On: "The Written Symbol Digit Modalities Test in Multiple Sclerosis is Sensitive to Cognitive and Motor Disability"Matthew A Greenwald, Héctor G Cancel Asencio, Kevin Hu, et al.
Therapeutic Advances in Neurological Disorders|February 8, 2021
Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trialsYinan Zhang, Natalia Gonzalez Caldito, Afsaneh Shirani, et al.
Pageof 34

Showing results (181-190 of 333) with videos related to

Sort By:
Pageof 34
Journal of the Neurological Sciences|May 22, 2016
Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trialSamuel F Hunter, Mark Agius, Deborah M Miller, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2025
Extended window of relapse recovery in RRMS: an analysis of the DECIDE datasetJop Mostert, Eva M Strijbis, Miguel D'Haeseleer, et al.
Antimicrobial Resistance and Infection Control|July 14, 2022
Clinical risk factors for admission with Pseudomonas and multidrug-resistant Pseudomonas community-acquired pneumoniaAdeniyi J Idigo, J Michael Wells, Matthew L Brown, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 2, 2013
The Multiple Sclerosis Intimacy and Sexuality Questionnaire -- re-validation and development of a 15-item version with a large US sampleFrederick W Foley, Vance Zemon, Denise Campagnolo, et al.
Statistics in Medicine|May 10, 2024
Novel non-linear models for clinical trial analysis with longitudinal data: A tutorial using SAS for both frequentist and Bayesian methodsGuoqiao Wang, Whedy Wang, Brian Mangal, et al.
Therapeutic Advances in Neurological Disorders|June 18, 2019
Clinical trials in multiple sclerosis: potential future trial designsNavid Manouchehri, Yinan Zhang, Amber Salter, et al.
Multiple Sclerosis and Related Disorders|May 27, 2025
The written symbol digit modalities test in multiple sclerosis is sensitive to cognitive and motor disabilityMatthew A Greenwald, Héctor G Cancel Asencio, Kevin Hu, et al.
Journal of General Internal Medicine|December 22, 2004
A practical randomized trial to improve diabetes careRussell E Glasgow, Paul A Nutting, Diane K King, et al.
Multiple Sclerosis and Related Disorders|April 3, 2026
Comments On: "The Written Symbol Digit Modalities Test in Multiple Sclerosis is Sensitive to Cognitive and Motor Disability"Matthew A Greenwald, Héctor G Cancel Asencio, Kevin Hu, et al.
Therapeutic Advances in Neurological Disorders|February 8, 2021
Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trialsYinan Zhang, Natalia Gonzalez Caldito, Afsaneh Shirani, et al.
Pageof 34